secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2024-01-25T23:59:59+00:00
Accession:  0001193125-24-015380
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inovio Pharmaceuticals effects 1-for-12 reverse stock split effective January 24, 2024
--------------------------------------------------------------------------------

- Every 12 issued and outstanding shares combined into 1 share; par value unchanged at $0.001.
- Fractional shares not issued; stockholders entitled to fractional shares receive cash based on Jan 24 closing price.
- Authorized shares of common stock remain at 600,000,000; no reduction.
- Proportionate adjustments made to stock options, Series C Convertible Preferred Stock, and equity incentive plans.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312524015380/0001193125-24-015380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312524015380/d736726d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-015380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer